Mycosis Fungoides Resisting Treatment with both Nitrogen Mustard and Anti-Reticular Cytotoxic Serum11From the Department of Dermatology and Syphilology, Temple University School of Medicine, Philadelphia, Pa.  by Friedman, Reuben & Stritzler, Conrad
PRELIMINARY AND SHORT REPORTS 
MYCOSIS FUNGOIDES RESISTING TREATMENT WITH BOTH NITROGEN 
MUSTARD AND ANTI-RETICULAR CYTOTOXIC SERUM* 
REUBEN FRIEDMAN' M.D 0 AND CONRAD STRITZ.LER, M.D 0 
Philadelphia, Pa. 
Prompted by the excellent result which, within a period of one week, followed the use of 
nitrogen mustard in a case of mycosis fungoides reported by Henstell and Tober1, we ad-
ministered this remedy to an advanced case of this disease. When, however, the therapy 
with nitrogen mustard proved ineffective, treatment with anti-reticular cytotoxic seruml 
was instituted. Our inability to find in the literature a report of a case of mycosis fungoides 
treated with both of these agents prompted us to report the results obtained in our case . 
CASE REPORT 
G. W., a 61 year old white male, a retired farmer, first came under our observation on 
March 10, 1947. He had generalized mycosis fungoides of many years duration. 
Examination revealed numerous crusted and ulcerated plaques of varying size and shape 
distributed over the scalp, face, trunk and all extremities. Many were red, harsh, dry, 
scaly and infiltrated. They were particularly extensive on the back and were crusted and 
coalescent about the hips . There was total alopecia of the patches involving the scalp. 
The ulcerated lesions had a foul odor. 
On June 2, 1947, the patient was admitted to Temple University Hospital. The biopsy of 
a nodule revealed definite mycosis fungoides . 
On June 4, 1947, the patient received 5.5 milligrams of nitrogen mustard intravenously, 
followed by 200 cc of 5 per cent glucose in normal saline . He weighed 55 kilograms, and the 
dose was calculated at the rate of 0.1 mgm per kilogram of body weight . This dose was 
repeated daily for four days. There was little reaction other than moderate nausea. After 
three weeks no significant changes had occurred in the cutaneous picture. A post-treat-
ment biopsy, on June 13, 1947, showed no changes. 
On June 26, 1947, through the cooperation of Dr. M. H. Samitz, of Philadelphia, Pa ., 
treatment with anti-reticular cytotoxic serum (ACS) was begun, with 0.5 cc given sub-
cutaneously; 1.0 cc was given four days later, and 1.5 cc four days after the second dose. 
Treatment was completed on July 4, 1947. Objectively, the patient showed little change. 
A week later, on July 11, he voluntarily stated that he felt much better and, for the first time 
in months, desired to be up and about. This subjective improvement, however, was short-
lived . Another post-treatment biopsy, on July 16, 1947, showed no change in the histologic 
picture . The patient was discharged from the hospital on July 16, 1947, unimproved. He 
died of the disease in October, 1947. 
COMMENT 
Compared with Henstell and Tober's patient, our case was in a much more advanced 
stage of the disease. Their patient was in the infiltrative stage while ours was in the ulcer-
ative stage, which may possibly account for his failure to respond to either of the two 
therapeutic agents we used . 
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Summary 
1. A case is reported of mycosis fungoides in the ulcerative stage, treated with both 
nitrogen mustard and anti-reticular cytotoxic serum (ACS) with no persistent clinical 
improvement. 
2. There was no change in the histological picture following either nitrogen mustard or 
ACS therapy. 
3. The transient symptomatic improvement following ACS therapy suggests the ad-
visability of follow-up therapy with small weekly or semi-weekly doses of ACS after the 
initial course of three injections at four-day intervals. 
